References
- Heber D, Lu QY (2002) Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood), 227, 920-923 https://doi.org/10.1177/153537020222701013
- Bae JW, Bae JS (2011) Barrier protective effects of lycopene in human endothelial cells. Inflamm Res, 60, 751-758 https://doi.org/10.1007/s00011-011-0330-9
- Goodwin GH, Sanders C, Johns EW (1973) A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem, 38, 14-19 https://doi.org/10.1111/j.1432-1033.1973.tb03026.x
- Bustin M, Reeves R (1996) High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol, 54, 35-100 https://doi.org/10.1016/S0079-6603(08)60360-8
- Boonyaratanakornkit V, Melvin V, Prendergast P, Altmann M, Ronfani L, Bianchi ME, Taraseviciene L, Nordeen SK, Allegretto EA, Edwards DP (1998) High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol, 18, 4471-4487 https://doi.org/10.1128/MCB.18.8.4471
- Mosevitsky MI, Novitskaya VA, Iogannsen MG, Zabezhinsky MA (1989) Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions. Eur J Biochem, 185, 303-310 https://doi.org/10.1111/j.1432-1033.1989.tb15116.x
- Andersson U, Tracey KJ (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immuno, 129, 139-162
- Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E,Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science, 285, 248-251 https://doi.org/10.1126/science.285.5425.248
- Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, Kurosawa S (1999) Inflammation, sepsis, and coagulation. Haematologica, 84, 254-259
- Alon R, Shulman Z (2011) Chemokine triggered integrin activation and actin remodeling events guiding lymphocyte migration across vascular barriers. Exp Cell Res, 317, 632-641 https://doi.org/10.1016/j.yexcr.2010.12.007
- Castellani ML, De Lutiis MA, Toniato E, Conti F, Felaco P, Fulcheri M, Theoharides T C, Caraffa A, Antinolfi P, Conti P, Cuccurullo C, Ciampoli C, Felaco M, Orso C, Salini V, Cerulli G, Kempuraj D, Tete S, Shaik B (2010) Impact of RANTES, MCP-1 and IL-8 in mast cells. J Biol Regu lHomeost Agents, 24, 1-6
- Bradle JR (2008) TNF-mediated inflammatory disease. J Pathol, 214, 149-160 https://doi.org/10.1002/path.2287
- Javaid K, Rahman A, Anwar KN, Frey RS, Minshall RD, Malik AB (2003) Tumor necrosis factor-alpha induces early-onset endothelial adhesivity by protein kinase Czeta-dependent activation of intercellular adhesion molecule-1. Circ Res, 92, 1089-1097. https://doi.org/10.1161/01.RES.0000072971.88704.CB
- Lockyer JM, Colladay JS, Alperin-Lea WL, Hammond T, Buda AJ (1998) Inhibition of nuclear factor-kappaB-mediated adhesion molecule expression in human endothelial cells. Circ Res, 82, 314-320 https://doi.org/10.1161/01.RES.82.3.314
- Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander R W, Medford RM (1993) Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest, 92, 1866-1874 https://doi.org/10.1172/JCI116778
- Jaulmes A, Thierry S, Janvier B, Raymondjean M, Marechal V (2006) Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. FASEB J, 20, 1727-1729 https://doi.org/10.1096/fj.05-5514fje
- Vadas P, Pruzanski W (1986) Role of secretory phospholipases A2 in the pathobiology of disease. Lab Invest, 55, 391-404
- Bae JS, Rezaie AR (2008) Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost, 100, 101-109 https://doi.org/10.1160/TH08-02-0127
- Dennis EA (1997) The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci, 22, 1-2 https://doi.org/10.1016/S0968-0004(96)20031-3
- Nakano T, Ohara O, Teraoka H, Arita H (1990) Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett, 261, 171-174 https://doi.org/10.1016/0014-5793(90)80663-4
- Oka S, Arita H (1991) Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem, 266, 9956-9960
- Menschikowski M, Hagelgans A, Siegert G (2006) Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins Other Lipid Mediat, 79, 1-33 https://doi.org/10.1016/j.prostaglandins.2005.10.005
- Hajjar DP, Pomerantz KB (1992) Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J, 6, 2933-2941 https://doi.org/10.1096/fasebj.6.11.1644257
- Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S (2004) Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol, 24, 2137-2142 https://doi.org/10.1161/01.ATV.0000143933.20616.1b
- Li Y, Schwabe RF, DeVries-Seimon T, Yao PM, Gerbod-Giannone MC., Tall AR, Davis RJ, Flavell R, Brenner DA, Tabas I (2005) Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem, 280, 21763-21772 https://doi.org/10.1074/jbc.M501759200
- Stoll LL, Denning GM, Weintraub NL (2006) Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. Curr Pharm Des, 12, 4229-4245 https://doi.org/10.2174/138161206778743501
- Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J, 22, 5551-5560 https://doi.org/10.1093/emboj/cdg516
- Par, JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham, E (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem, 279, 7370-7377 https://doi.org/10.1074/jbc.M306793200
- Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ (2000) High mobility group1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 192, 565-570 https://doi.org/10.1084/jem.192.4.565
- Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med, 164, 1768-1773 https://doi.org/10.1164/ajrccm.164.10.2106117